Today's Top Performers In Health Services
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.All three major indices are trading up today with the Dow Jones Industrial Average (^DJI) trading up 11 points (0.1%) at 16,218 as of Tuesday, Feb. 25, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,600 issues advancing vs. 1,298 declining with 186 unchanged.The Health Services industry currently sits down 0.4% versus the S&P 500, which is up 0.2%. A company within the industry that increased today was Agilent Technologies (A), up 1.2%. On the negative front, top decliners within the industry include Tenet Healthcare (THC), down 8.0%, Fresenius Medical Care AG & Co. KGaA (FMS), down 5.4%, Community Health Systems (CYH), down 3.9%, ResMed (RMD), down 2.9% and DaVita HealthCare Partners (DVA), down 1.5%.TheStreet would like to highlight 3 stocks pushing the industry higher today:3. Catamaran (CTRX) is one of the companies pushing the Health Services industry higher today. As of noon trading, Catamaran is up $1.08 (2.1%) to $52.49 on average volume. Thus far, 785,109 shares of Catamaran exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $51.35-$52.73 after having opened the day at $51.72 as compared to the previous trading day's close of $51.41. Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $10.5 billion and is part of the health care sector. Shares are up 7.7% year-to-date as of the close of trading on Monday. Currently there are 12 analysts who rate Catamaran a buy, no analysts rate it a sell, and 5 rate it a hold.TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, good cash flow from operations and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Catamaran Ratings Report now.3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV